October 18, 2023
12:00 – 1:00 PM PST
Webinar Recording
Presentation Slides
CME Evaluation
 

In this webinar, Dr. Mauseth will identify current trends in behavioral health, recommend specific evidence-based resilience and coping strategies for at-risk populations, and increase awareness and facility about cross-cultural communication and behavioral health issues.

Educational Objectives

Upon completion of this educational activity, participants should be able to:

1. Identify current trends in behavioral health.
2. Recommend specific evidence-based resilience and coping strategies for populations at risk.
3. Create awareness and facility about cross-cultural communication about behavioral health issues.

Target Audience

This activity is designed to educate commission members, practitioners, medical regulatory staff, and the public.

Speaker Biography

Kira Mauseth, PHD

Dr. Kira Mauseth is a clinical psychologist who sees patients at Snohomish Psychology Associates in Everett and Edmonds, WA, a Senior Instructor at Seattle University, and a co-lead for the Behavioral Health Strike Team for DOH. She also owns Astrum Health, LLC, and consults with organizations and educational groups about local disaster preparedness and resilience building.

Dr. Mauseth has trained community groups and professionals both regionally and abroad as the co-developer of the Health Support Team© program. Her work and research focus on disaster behavioral health, resilience, and recovery from trauma, as well as small and large-scale critical incident response and preparation for organizations. She has worked abroad extensively with disaster survivors and refugees, has trained first responders and health care workers throughout Puget Sound and the U.S., and currently serves as adult mental health clinical representative on the WA State Disaster Medical Advisory Committee (DMAC).

 

 

 

 

Continuing Medical Education

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Federation of State Medical Boards, the Washington Medical Commission, and the Washington State Department of Health. The Federation of State Medical Boards is accredited by the ACCME to provide continuing medical education for physicians. The Federation of State Medical Boards designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Credit Designation Statement

The Federation of State Medical Boards designates this internet enduring activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Course Director

Morgan Barrett, MD
Washington Medical Commission

Commercial Support

This learning activity is not funded by any commercial entity.

Disclosure Declaration

As an organization accredited by the ACCME, the Federation of State Medical Boards (FSMB) requires that the content of CME activities and related materials provide balance, independence, objectivity, and scientific rigor. All faculty, planners, and others in a position to control continuing medical education content participating in an accredited continuing education activity are required to disclose all financial relationships with ineligible companies. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Faculty (authors, presenters, speakers and planners) are encouraged to provide a balanced view of therapeutic options by utilizing either generic names or other options available when utilizing trade names to ensure impartiality.

Faculty members are asked to disclose all financial relationships they have had in the past 24 months with ineligible companies regardless of the potential relevance of each relationship to the education and of the amount. The FSMB has implemented a mechanism to identify and resolve all  conflicts of interest prior to the activity. The intent of this policy is to identify potential conflicts of interest so participants can form their own judgments with full disclosure of the facts. Participants will be asked to evaluate whether the speaker’s outside interests reflect a possible bias in the planning or presentation of the activity. The speakers, course director, and planners at the Federation of State Medical Boards, have nothing to disclose

Disclosure of Unlabeled Uses

This educational activity may contain discussion of published and/or investigational uses of agents that are not approved by the U.S. Food and Drug Administration. For additional information about approved uses, including approved indications, contraindications, and warnings, please refer to the prescribing information for each product, or consult the Physicians’ Desk Reference.

Faculty and Staff Disclosures

No speaker or persons in control of content reported intent to reference unlabeled/unapproved uses of drugs or products.